Key facts
- This page summarizes Lori Bisson's Form 4 filing for Autonomix Medical, Inc. (AMIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Sep 2026, 16:21.
Lori Bisson - 03 Sep 2026 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)
- Reporting relationship
- Director
- Issuer ticker
- AMIX
- Reported as of
- 03 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Sep 2026, 16:21:06 UTC
- Prior SEC filing
- 13 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Trent Smith, Attorney-in-Fact for Lori Bisson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lori Bisson filed Form 4 for Autonomix Medical, Inc. (AMIX) on 08 Sep 2026.
Change
- Previous filing in this sequence was filed on 13 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001768578
Primary reporting owner
Bisson Lori
- Relationship
- Director
- Address
- 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
- Signature
- /s/ Trent Smith, Attorney-in-Fact for Lori Bisson
- Signature date
- 08 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMIX
transaction
Common Stock
Award
- Transaction value
- Shares
- +13,000
- Change %
- +10924%
- Price
- Shares after
- 13,119
- Date
- 03 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.